You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE Test

Can Vaccination Lower Risk for Long COVID for Patients With Rheumatic Disease?

To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

  1. You are a member of the healthcare team advising a large rheumatology practice regarding optimal preventive strategies against COVID-19. On the basis of the large, prospective survey study by Wallace and colleagues, which one of the following statements about the association of vaccination against SARS-CoV-2 with risk for postacute sequelae of COVID-19 (PASC) in patients with systemic autoimmune rheumatic diseases (SARDs) is correct?
    At 90 but not 28 days, the percentage of fully vaccinated vs unvaccinated/partially vaccinated patients with PASC was significantly higher
    For PASC in fully vs unvaccinated/partially vaccinated patients, adjusted odds ratio was 0.49 at 28 days and 0.10 at 90 days
    Anosmia and joint pain were more common in patients with breakthrough vs nonbreakthrough COVID-19 infection
    Patients with breakthrough vs nonbreakthrough infection had similar patient-reported pain and fatigue scores
  2. According to the large, prospective survey study by Wallace and colleagues, which one of the following statements about clinical and public health implications of the association of vaccination against SARS-CoV-2 with risk for PASC in patients with SARDs is correct?
    The findings suggest that vaccination is of limited benefit in patients with SARDs
    The study proves that vaccination prevents PASC in patients with SARDs
    The findings highlight the ongoing need to clarify the etiology of PASC in patients with SARD and to identify effective treatments
    The study proves that booster doses further reduce risk for PASC in patients with SARDs